These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 32719235)

  • 1. A survey of clinical practices among oncologists regarding hepatitis B screening in patients with cancer.
    Sundaram S; Patil P; Sengar M; Rathod R; Mehta S
    Indian J Med Res; 2020 Jun; 151(6):604-608. PubMed ID: 32719235
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Screening for hepatitis B in chemotherapy patients: survey of current oncology practices.
    Tran TT; Rakoski MO; Martin P; Poordad F
    Aliment Pharmacol Ther; 2010 Jan; 31(2):240-6. PubMed ID: 19814747
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical practice of hepatitis B screening in patients starting with chemotherapy: A survey among Dutch oncologists.
    Leber K; Otten HJMMB; Brandjes DPM; Claassen MAA; Lauw FN
    Eur J Cancer Care (Engl); 2021 Nov; 30(6):e13495. PubMed ID: 34310787
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Real-world prevalence of hepatitis B virus reactivation in cancer patients in Taiwan.
    Chen CH; Hsieh HH; Wu TY
    J Oncol Pharm Pract; 2021 Jan; 27(1):63-70. PubMed ID: 32264743
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Current hepatitis B screening practices and clinical experience of reactivation in patients undergoing chemotherapy for solid tumors: a nationwide survey of medical oncologists.
    Day FL; Link E; Thursky K; Rischin D
    J Oncol Pract; 2011 May; 7(3):141-7. PubMed ID: 21886492
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oncologists and hepatitis B: a survey to determine current level of awareness and practice of antiviral prophylaxis to prevent reactivation.
    Khokhar OS; Farhadi A; McGrail L; Lewis JH
    Chemotherapy; 2009; 55(2):69-75. PubMed ID: 19077421
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatitis B reactivation in cancer patients: role of prechemotherapy screening and antiviral prophylaxis.
    Kawsar HI; Shahnewaz J; Gopalakrishna KV; Spiro TP; Daw HA
    Clin Adv Hematol Oncol; 2012 Jun; 10(6):370-8. PubMed ID: 22895238
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Community prevalence of hepatitis B infection and modes of transmission in Tamil Nadu, India.
    Kurien T; Thyagarajan SP; Jeyaseelan L; Peedicayil A; Rajendran P; Sivaram S; Hansdak SG; Renu G; Krishnamurthy P; Sudhakar K; Varghese JC;
    Indian J Med Res; 2005 May; 121(5):670-5. PubMed ID: 15937371
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Infection with hepatitis viruses (B and C) and human retroviruses (HTLV-1 and HIV) in Saudi children receiving cycled cancer chemotherapy.
    Bakir TM; Kurbaan KM; al Fawaz I; Ramia S
    J Trop Pediatr; 1995 Aug; 41(4):206-9. PubMed ID: 7563271
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Practice Patterns in Hepatitis B Virus Screening Before Cancer Chemotherapy in a Major US Hospital Network.
    Kwak YE; Stein SM; Lim JK
    Dig Dis Sci; 2018 Jan; 63(1):61-71. PubMed ID: 29177849
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatitis B virus reactivation in cancer patients with positive Hepatitis B surface antigen undergoing PD-1 inhibition.
    Zhang X; Zhou Y; Chen C; Fang W; Cai X; Zhang X; Zhao M; Zhang B; Jiang W; Lin Z; Ma Y; Yang Y; Huang Y; Zhao H; Xu R; Hong S; Zhang L
    J Immunother Cancer; 2019 Nov; 7(1):322. PubMed ID: 31753012
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High hepatitis B virus screening rate among patients receiving systemic anticancer treatment in Japan.
    Yazaki S; Yamauchi T; Higashi T
    Int J Clin Oncol; 2020 Jul; 25(7):1327-1333. PubMed ID: 32200482
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatitis B virus reactivation in patients receiving chemotherapy for malignancies: role of precore stop-codon and basic core promoter mutations.
    Alexopoulou A; Theodorou M; Dourakis SP; Karayiannis P; Sagkana E; Papanikolopoulos K; Archimandritis AJ
    J Viral Hepat; 2006 Sep; 13(9):591-6. PubMed ID: 16907845
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence and chemotherapy-induced reactivation of occult hepatitis B virus among hepatitis B surface antigen negative patients with diffuse large B-cell lymphoma: significance of hepatitis B core antibodies screening.
    Elbedewy TA; Elashtokhy HE; Rabee ES; Kheder GE
    J Egypt Natl Canc Inst; 2015 Mar; 27(1):11-8. PubMed ID: 25716703
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of hepatitis B surface antigen in hepatitis B virus relapse after entecavir or tenofovir prophylaxis in patients undergoing cancer chemotherapy.
    Kuo MT; Tseng PL; Chou YP; Chang KC; Tsai MC; Kuo YH; Hu TH; Hung CH; Wang JH; Lu SN; Chen CH
    J Gastroenterol Hepatol; 2018 Oct; 33(10):1766-1772. PubMed ID: 29514418
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of prophylactic antiviral therapy and outcomes in HBsAg-negative, anti-HBc-positive patients receiving chemotherapy: a real-life experience.
    Papadopoulos N; Deutsch M; Manolakopoulos S; Bitsi C; Michalakeas H; Poulakidas H; Tsironi E; Giannouli S; Papatheodoridis GV; Koskinas J; Pectasides D
    Eur J Gastroenterol Hepatol; 2017 Jan; 29(1):56-60. PubMed ID: 27669175
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk of hepatitis B virus (HBV) reactivation in hepatitis B surface antigen negative/hepatitis B core antibody positive patients receiving rituximab-containing combination chemotherapy without routine antiviral prophylaxis.
    Koo YX; Tay M; Teh YE; Teng D; Tan DS; Tan IB; Tai DW; Quek R; Tao M; Lim ST
    Ann Hematol; 2011 Oct; 90(10):1219-23. PubMed ID: 21520001
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cost-effectiveness of a hepatitis B virus screening strategy to prevent reactivation in patients with hematologic neoplasms.
    Crespo J; Esteban R; Torres C; Oyagüez I; Casado MÁ; Buti M
    Rev Esp Enferm Dig; 2017 Sep; 109(9):619-626. PubMed ID: 28648087
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Status of hepatitis B infection - a decade after hepatitis B vaccination of susceptible Nicobarese, an indigenous tribe of Andaman & Nicobar (A&N) islands with high hepatitis B endemicity.
    Bhattacharya H; Bhattacharya D; Ghosal SR; Roy S; Sugunan AP
    Indian J Med Res; 2015 May; 141(5):653-61. PubMed ID: 26139785
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical and virological factors associated with hepatitis B virus reactivation in HBsAg-negative and anti-HBc antibodies-positive patients undergoing chemotherapy and/or autologous stem cell transplantation for cancer.
    Borentain P; Colson P; Coso D; Bories E; Charbonnier A; Stoppa AM; Auran T; Loundou A; Motte A; Ressiot E; Norguet E; Chabannon C; Bouabdallah R; Tamalet C; Gérolami R
    J Viral Hepat; 2010 Nov; 17(11):807-15. PubMed ID: 20002298
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.